Ibuprofen

Analytical Profiles of Drug Substances and Excipients

Volumn 27, Issue C, 2001, Pages 265-300

  Higgins, John D ^a   Gilmor, Timothy P ^a   Martellucci, Stephan A ^a   Bruce, Richard D ^a   Brittain, Harry G ^b  

^a McNeil Laboratories Inc   (United States)

^b Center for Pharmaceutical Physics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0011223331     PISSN: 10756280     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1075-6280(01)27008-6     Document Type: Chapter

References (65)

1. Rainsford K.D. An excellent review of many of the chemical, physiologic and clinical aspects of ibuprofen is found. Ibuprofen (1999), Taylor and Francis Publishers, London, UK
2. Royer G.L., Seckman B.S., and Welshman I.R. The clinical safety and efficacy of ibuprofen has been reviewed extensively; for example see. Am. J. Med. (1984) July 13 issue 25
3. Mayerand J.M., and Testa B. Drugs of the Future 22 (1997) 1347
4. Hardman J.G., Limbrid L.E., Molinoff P.B., Ruddon R.W., and Gilman A.G. The Pharmacological Basis of Therapeutics (1996), McGraw Hill, NY Chapter 27
5. G.P. Stahly, R.M. Starrett, Chirality in Industry A.N. Collins 1997 pp. 19-38
6. R.A. Dytham, GB Patent 1160725 1969
7. V. Elango, M.A. Murphy, B.L. Smith, K.G. Davenport, G.N. Moft, G.L. Moss, Eur. Pat. Appl. 284, 310 1988
8. McConnell J.F. Cryst. Struct. Comm. 3 (1974) 73
9. Shankland N., Wilson C.C., Florence A.J., and Cox P.J. Acta Cryrt. C53 (1997) 951
10. Shankland N., Florence A.J., Cox P.J., Wilson C.C., and Shankland K. Int. J. Pharm. 165 (1998) 107
11. Romero A.K., Savastano L., and Rhodes C.T. Int. J. Pharm. 99 (1993) 125
12. Labhasetwar V., Deshmukh S.V., and Dorle A.K. Drug Dev. Indust. Pharm. 19 (1993) 631
13. Khan G.M., and Jiabi Z. Drug Dev. Indust. Pharm. 24 (1998) 463
14. McCauley J.A. AIChE Symp. Series 87 (1991) 58
15. Romero A.J., Lukas G., and Rhodes C.T. Pharm. Acta. Helv. 66 (1991) 34
16. P. Gong, ICDD pattern 32-1723 grant-in-aid, (1981) primary reference, Polytechnic Inst, of Brooklyn, NY, USA
17. Stahly G.P., McKenzie A.T., Andres M.C., Russell C.A., Byrn S.R., and Johnson P. J. Pharm. Sci. 86 (1997) 970
18. Tung H.H., Waterson S., Reynolds S., and Paul E. AIChE Symp. Series 87 (1991) 64
19. Manimaran T., and Stahly G.P. Tetrahedron Asymmetry 4 (1993) 1949
20. Ebbers E.J., Plum B.J.M., Ariaans G.J.A., Kaptein B., Broxterman Q.B., Bruggink A., and Zwanenburg B. Tetrahedron Asymmetry 8 (1997) 4047
21. Dwivedi S.K., Sattari S., Jamali F., and Mitchell A.G. Int. J. Pharm. 87 (1992) 95
22. The Merck Index, 10th edn., 1983, p. 712
23. Unpublished results, McNeil Consumer Healthcare, Fort Washington, PA
24. Ertel K.D., Heasley R.A., Koegel C., Chakrabarti A., and Carstensen J.T. J. Pharm. Sci 79 (1990) 552
25. Schmid S., Mueller-Goymann C.C., and Schmitd P.C. Int. J. Pharm. 197 (2000) 35
26. Since ibuprofen is only sparingly soluble in water, pKa values in pure water have been calculated from values determined in binary water/organic solvent mixtures. See for example
27. Takas-Novak K., Box K.J., and Avdeef A. Int. J. Pharm. 151 (1997) 235
28. Rafols C., Roses M., and Bosch E. Anal. Chim. Acta 350 (1997) 255
29. H.G. Brittain, unpublished results obtained using ACD/PhysChem, Advanced Chemistry Development, Toronto, CA
30. Solubility data provided by BASF Corporation, Bishop, TX
31. Lelsing G., Resel R., Stelzer F., Tasch S., Lanzier A., and Hantich G. J. Clin. Pharmacol. 36 (1996) 3S
32. Hewlet Packard MS Chemstation Library (1995), John Wiley & Sons, Inc., New York
33. USP 24 The United States Pharmacopoeial Convention, Rockville, MD, p. 854
34. Ravi J., Jain C.L., and Bansal Y.K. Indian Drugs 27 (1990) 615
35. Sen A.K., Bandyopadhyay A., Podder G., and Chowdhury B.J. J. Indian Chem. Soc 67 (1990) 443
36. Lampert B.M., and Stewart J.T. J. Chromatogr. 504 (1990) 381
37. Husain S., Murty A.S.R., and Narasimha R. Indian Drugs 26 (1989) 557
38. Tsao J.C., and Savage T.S. Drug Dev. Ind. Pharm. 11 (1985) 1123
39. Aravind M.K., Miceli J.N., and Kauffman R.E. J. Chromatogr. 308 (1984) 350
40. Kamei K., Kitahara K., Momose A., Matsuura K., and Yuki H. Shitsutyo Bunseki 36 (1988) 115
41. Haikala V.E., Heimonen I.K., and Vuorela H.J. J. Pharm. Sci. 80 (1991) 456
42. Rao G.R., Avadhanulu A.B., and Pantulu A.R.R. East. Pharm. 34 (1991) 119
43. Pant S.K., and Jain C.L. Indian Drugs 28 (1991) 262
44. Heikkinen L. Acta Pharm. Fenn. 92 (1983) 275
45. Budvari-Barany Z., Radeczky G., Shalaby A., and Szasz G. Acta Pharm. Hung. 59 (1989) 49
46. The British Pharmacopoeia 1999 (1999), The Stationary Office
47. Rustum A.M. J. Chromatogr. Sci. 29 (1991) 16
48. Shah A., and Jung D. Chromatographia 378 (1986) 232
49. Rifia N., Sakamoto M., Law T., Gaipchian V., Harris N., and Colin A. Clin. Chem. 42 (1996) 1812
50. Hercegova A., and Polonsky J. Pharmazie 54 (1999) 479
51. Kaiser D.G., and Vangiessen J. J. Pharm. Sci. 63 (1974) 219
52. Kaiser D.G., and Martin R.S. J. Pharm. Sci. 67 (1978) 627
53. Ibuprofen USP Customer Dossier BASF Corporation Bishop, TX
54. Chauhan S., and Sahoo B. Bioorg. Med Chem. 7 (1999) 2629
55. Albert K.S. Am. J. Med. (1984) 40 July 13
56. Lockwood G.F., Albert K.S., Gillespie M.S., Bole M.D., Harkcom M.D., Szpunar B.S., and Wager J.G. Pharmacol Therap. 34 (1983) 97
57. Adams S.S., Gough G., Cliffe E., Lessel B., and Mills R. Tox. Appl. Pharm. 15 (1969) 310
58. Evans A.M. J. Clin. Pharmacol 36 (1996) 7
59. Rudy A.C., Anlikerand K.S., and Hall S.D. J. Chromatog. 538 (1990) 395
60. Rudy A.C., Knight P.M., Brater D.C., and Hall S.D. J. Pharmacol. Exp. Therap. 273 (1995) 8893
61. Leeman Td. Drug Exp. Clin. Res. 19 (1993) 189
62. Lee E.J.D., Williams K., Day R., Graham G., and Champion D. J. Clin. Pharmacol. 19 (1985) 669
63. Mills R.F.N., Adams S., Cliffe E., Dickenson W., and Nicholson J. Xeneobiotica 3 (1973) 589
64. Cheng H., Rogers J., Demetriades J., Holland S., Seibold J., and Depuy E. Pharm. Res. 11 (1994) 824
65. Baellie T.A., Adams W., and Kaiser D. Pharmacol. Exp. Therap. 249 (1989) 517